Top Gainers: Fuwei Films (Holdings) (NASDAQ:FFHL), Elephant Talk Communications (NYSEMKT:ETAK), China XD Plastics (NASDAQ:CXDC), Keryx Biopharmaceuticals (NASDAQ:KERX)

1352

Fuwei Films (Holdings) Co., Ltd. (Nasdaq:FFHL) 19.5% HIGHER; announced that the Company has become aware that the fifth public auction by which the Company’s controlling shareholder, the Weifang State-owned Assets Operation Administration Company, a wholly-owned subsidiary of Weifang State-owned Asset Management and Supervision Committee (collectively, the “Administration Company”) sought to sell control over 6,912,503 (or 52.9%) of its outstanding ordinary shares, resulted in the acceptance of a successful bid. On last trading day Fuwei Films (Holdings) Co., Ltd (NASDAQ:FFHL) ended up 1.88% higher/lower to close at $1.88 while trading in the range of $1.55- $2.24. Its return on assets (ROA) is -11.90% while return on investment (ROI) is -8.10%. Fuwei Films (Holdings) Co., Ltd (NASDAQ:FFHL) monthly performance is54.10%.

Shares of Elephant Talk Communications Corp (NYSEMKT:ETAK) are up 10.8% to $1.23 in trading Wednesday. The mobile networking software company reported 2013 fourth quarter revenue of $6 million, a 64% increase from the previous fourth quarter of $3.6 million. Elephant Talk Communications Corp (NYSEMKT:ETAK) in last trading activity ended up at $1.32 with day range of $1.12 – $1.36. Company weekly performance is 15.79% while its quarterly performance stands at 5.60%. Elephant Talk Communications Corp (NYSEMKT:ETAK) is -26.26% away from its 52 week high.

China XD Plastics Company Limited (Nasdaq:CXDC) $5.88. China XD Plastics moving to a new high after it reported Q4 revs of $384.6 million and net income of $57.5 million, China XD Plastics Co Ltd (NASDAQ:CXDC) belongs to Consumer Goods sector with market capitalization of 274.77 B and has 68.18% insider ownership. In last trading activity company’s stock closed at $5.74 while opening price was $5.45.

Keryx Biopharmaceuticals (NASDAQ:KERX) has suddenly soared sharply to the upside in the last few minutes on heavy volume. The stock is currently up 18.50% to $16.69 after hitting session high of $17.29. The stock made a new 52-week high today as well. We could not find any official news as of yet. On Wednesday shares of Keryx Biopharmaceuticals (NASDAQ:KERX) opened at $ 14.20 and closed at $16.54. This year Company’s Earnings per Share (EPS) growth is -65.70% and next year’s estimated EPS growth is 202.00%. Analysts mean target price for is Keryx Biopharmaceuticals (NASDAQ:KERX) $24.09.

Get Free Updates and Stock Alerts!



*We only send one email per week
Share.

Get Winning Stock Alerts!

Our track record speaks for itself! Our last 7 alerts have delivered combined gains in excess of 300% and there are no signs of slowing down. Join UltimateStockAlerts.com now before you miss out on our next big runner!

We will never sell or share your information.